QTRX: Quanterix Corp.
About
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Current Value
$11.001 Year Return
Current Value
$11.001 Year Return
Key Details
Market Cap
$424.47M
P/E Ratio
-10.59
1Y Stock Return
-53.12%
1Y Revenue Growth
15.52%
Dividend Yield
0.00%
Price to Book
1.3
Strategies that include QTRX
Stock's related to QTRX
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SIBN | 46.45% | $516.68M | -29.40% | 0.00% |
| RPAY | 46.39% | $692.43M | +8.68% | 0.00% |
| PRO | 43.99% | $1.05B | -39.43% | 0.00% |
| FMNB | 43.82% | $570.21M | +22.73% | 4.50% |
| TREE | 42.23% | $573.76M | +169.05% | 0.00% |
| BLFS | 42.00% | $1.04B | +64.64% | 0.00% |
| AIV | 41.69% | $1.25B | +32.83% | 0.00% |
| GPRO | 41.25% | $179.52M | -67.23% | 0.00% |
| HONE | 40.67% | $572.67M | +17.97% | 2.43% |
| STHO | 40.57% | $150.51M | -5.99% | 0.00% |
| KRNY | 40.52% | $526.32M | +4.49% | 5.40% |
| PGEN | 40.32% | $228.91M | -28.00% | 0.00% |
| PACB | 40.28% | $471.05M | -79.23% | 0.00% |
| NEP | 40.28% | $1.48B | -32.95% | 22.91% |
| NTB | 40.08% | - | - | 4.69% |
| CLFD | 40.06% | $398.66M | +4.48% | 0.00% |
| SIG | 39.99% | $4.17B | +17.93% | 1.17% |
| RLGT | 39.88% | $334.04M | +15.02% | 0.00% |
| TY | 39.84% | - | - | 3.32% |
| AROW | 39.70% | $546.36M | +34.05% | 4.19% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NOC | 0.05% | $71.54B | +4.23% | 1.60% |
| LU | 0.15% | $2.01B | -33.75% | 0.00% |
| NGL | 0.17% | $572.94M | +5.60% | 0.00% |
| IMRN | 0.19% | $10.31M | -5.04% | 0.00% |
| MNOV | -0.25% | $93.19M | +2.15% | 0.00% |
| LTM | -0.28% | $8.51B | -100.00% | <0.01% |
| QXO | -0.32% | $6.51B | -35.95% | 0.00% |
| BACK | 0.42% | $1.76M | -32.90% | 0.00% |
| IMMP | -0.47% | $293.82M | +8.31% | 0.00% |
| SYPR | 0.50% | $32.23M | -26.32% | 0.00% |
| VSTA | -0.55% | $204.94M | -39.33% | 0.00% |
| FATBB | -0.58% | $81.94M | -12.91% | 11.69% |
| CRNT | 0.80% | $267.92M | +70.49% | 0.00% |
| LFWD | 0.82% | $16.21M | -63.99% | 0.00% |
| TBRG | -0.96% | $244.47M | +52.66% | 0.00% |
| XGN | 0.99% | $62.26M | +127.74% | 0.00% |
| KSPI | -1.10% | $20.86B | +18.06% | 3.37% |
| LITB | -1.12% | $35.48M | -75.45% | 0.00% |
| KMB | 1.14% | $45.22B | +11.57% | 3.58% |
| GRFS | 1.28% | $2.18B | -11.41% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PULM | -27.19% | $19.83M | +202.98% | 0.00% |
| TPST | -17.93% | $37.75M | -77.59% | 0.00% |
| COR | -12.68% | $47.48B | +21.20% | 0.86% |
| QNTM | -10.67% | $9.19M | -94.36% | 0.00% |
| HUSA | -10.01% | $16.69M | -11.56% | 0.00% |
| PGR | -8.79% | $149.10B | +57.29% | 0.45% |
| CBOE | -8.41% | $21.46B | +15.84% | 1.11% |
| URGN | -6.98% | $470.95M | -11.92% | 0.00% |
| MCK | -6.61% | $78.15B | +35.51% | 0.42% |
| STG | -6.15% | $35.67M | +7.92% | 0.00% |
| CAH | -5.81% | $28.64B | +12.14% | 1.70% |
| BTCT | -5.80% | $42.61M | +353.33% | 0.00% |
| OXBR | -5.53% | $19.05M | +178.18% | 0.00% |
| EDSA | -5.41% | $7.11M | -21.79% | 0.00% |
| PRPO | -4.90% | $9.10M | -13.65% | 0.00% |
| TEM | -4.76% | $8.50B | 0.00% | 0.00% |
| RDDT | -4.30% | $24.08B | +303.41% | 0.00% |
| MSDL | -3.66% | $1.83B | +0.66% | 7.26% |
| NNE | -3.64% | $833.66M | +531.50% | 0.00% |
| VHC | -3.53% | $19.06M | -38.36% | 0.00% |
ETF's related to QTRX
News
Finnhub
Advance Tests Launches the LucentAD Complete Test, Bringing New Standards of Alzheimer's Detection and Accessibility to the UKLondon - Advance Tests, a pioneer in advanced diagnostics, today...
Finnhub
SAN FRANCISCO, Nov. 15, 2024 -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of Qaunterix Corporation...
Finnhub
Law Offices of Howard G. Smith announces an investigation on behalf of Quanterix Corporation investors concerning the Company’s possible violations of federal securities laws.On November 12,...
Finnhub
The Law Offices of Frank R. Cruz announces an investigation of Quanterix Corporation on behalf of investors concerning the Company’s possible violations of federal securities laws.If you are a...
Yahoo
Quanterix Corp (QTRX) reports its sixth consecutive quarter of double-digit revenue growth, despite facing hurdles in instrument sales and regional revenue declines.
Yahoo
BILLERICA, Mass., November 12, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial results for the third quarter ended September 30, 2024 and reaffirmed its full year 2024 guidance. The Company also disclosed the need to restate certain prior period financial statements to correct non-cash errors related to those periods.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.